Marksans Pharma Limited
NSE: MARKSANS · Healthcare
₹318.50
-5.40 (-1.67%)
Last close · 30 Aug 2026, 2:50 am IST
- Open
- ₹326.30
- Day high
- ₹330.75
- Day low
- ₹315.10
- Volume
- 16.86 L
- Prev close
- ₹323.90
Price chart
Range
EMA
Also show
Fundamentals
Drug Manufacturers - General
Valuation
- Market Cap
- 11,161 Cr
- Price
- 246.30
- P/E (TTM)
- 26.68
- P/E (Fwd)
- 18.24
- P/B
- 3.69
- EV/EBITDA
- 17.55
- EV/Revenue
- 3.57
- PEG
- 1.12
- Div Yield
- 0.37%
- 52W High
- 281.60
- 52W Low
- 155.00
- Beta
- 1.09
Profitability & income
- Revenue (TTM)
- 2,951 Cr
- Net Income (TTM)
- 418 Cr
- EBITDA
- 601 Cr
- Gross Margin
- 56.72%
- Op. Margin
- 19.99%
- Net Margin
- 14.16%
- ROE
- 15.16%
- ROA
- 8.84%
- EPS (TTM)
- 9.23
- EPS (Fwd)
- 13.50
Financial health
- Total Debt
- 343 Cr
- Total Cash
- 990 Cr
- Debt/Equity
- 11.25
- Current Ratio
- 5.17
- Quick Ratio
- 3.12
- Book Value
- 66.74
- Free Cash Flow
- 70 Cr
- Op. Cash Flow
- 458 Cr
Growth
- Revenue Growth
- 20.80%
- Earnings Growth
- 63.50%
- Earnings QoQ
- 63.60%
Quarterly results
| Period | Revenue | Net Income | EBITDA | Op. Income | Gross Profit | Op. Cash Flow | Total Debt | Equity |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 856 Cr | 148 Cr | 231 Cr | 171 Cr | 465 Cr | — | 343 Cr | 3,023 Cr |
| 2025-12-31 | 754 Cr | 113 Cr | 181 Cr | 136 Cr | 438 Cr | — | — | — |
| 2025-09-30 | 720 Cr | 98 Cr | 166 Cr | 118 Cr | 412 Cr | — | 332 Cr | 2,688 Cr |
| 2025-06-30 | 620 Cr | 58 Cr | 106 Cr | 77 Cr | 358 Cr | — | — | — |
| 2025-03-31 | 708 Cr | 91 Cr | 142 Cr | 104 Cr | 383 Cr | — | 322 Cr | 2,467 Cr |
Annual results
| Period | Revenue | Net Income | EBITDA | Op. Income | Gross Profit | Op. Cash Flow | Total Debt | Equity |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 2,951 Cr | 418 Cr | 683 Cr | 502 Cr | 1,674 Cr | 458 Cr | 343 Cr | 3,023 Cr |
| 2025-03-31 | 2,623 Cr | 381 Cr | 599 Cr | 449 Cr | 1,479 Cr | 207 Cr | 322 Cr | 2,467 Cr |
| 2024-03-31 | 2,174 Cr | 314 Cr | 509 Cr | 387 Cr | 1,077 Cr | 230 Cr | 244 Cr | 2,065 Cr |
| 2023-03-31 | 1,850 Cr | 266 Cr | 395 Cr | 313 Cr | 892 Cr | 237 Cr | 123 Cr | 1,745 Cr |
| 2022-03-31 | — | — | — | — | — | — | — | — |
Figures in ₹ crore unless stated. Ratios and margins are trailing twelve months where marked TTM.
Want charts and signals for MARKSANS?
Sign in for candlestick charts with Supertrend, MACD and VWAP overlays, plus watchlists and email alerts.
Sign in